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Reservoir cells latently infected with HIV-1 pose one of the major obstacles that hamper ultimate eradication of HIV-1 from infected patients.
In this report, we showed that direct contact with MOLT-4 T cells induced HIV-1 replication in J22-HL-60 latently infected cells without any
additional stimulus. Neutralization experiments revealed that pro-inflammatory cytokines, whose production was increased following cell–cell
contact, were unlikely to be primarily involved in the induced HIV-1 replication. Cell–cell contact, but not soluble components in the culture
supernatant, caused a rapid phosphorylation and degradation of IκBα, which led to elevated NF-κB DNA binding activity in J22-HL-60 cells.
Furthermore, forced expression of a super-repressor form of IκBα or pretreatment with ritonavir efficiently blocked the activation of NF-κB and
HIV-1 replication in J22-HL-60 cells co-cultured with MOLT-4 T cells. Moreover, either resting or PHA stimulated primary CD4
+ T cells induced
HIV-1 replication in J22-HL-60 cells in a similar way with that of MOLT-4 cells. These results indicated that direct contact with CD4
+ T cells
induced HIV-1 replication in latently infected cells and provide insight into the molecular mechanism of virus release from myeloid progenitor
cells latently infected with HIV-1.
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The use of highly active antiretroviral therapy (HAART) in
HIV-1-infected individuals has dramatically improved the
clinical outcome in a majority of infected patients (reviewed
in Pomerantz and Horn, 2003). However, the presence of
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doi:10.1016/j.virol.2006.11.014producing infectious particles after cellular activation leads to
a rebound of the viral load after interruption of HAART
(Pierson et al., 2000). The persistence of these latently infected
viral reservoirs, despite prolonged HAART treatments, repre-
sents a major obstacle to the eradication of HIV-1 in infected
patients (Finzi et al., 1997; Wong et al., 1997). CD4+ T cells are
thought to be the major reservoirs of both actively replicating
and latent HIV-1 throughout the course of the disease
(Bukrinsky et al., 1991; Siliciano et al., 2003). In addition to
CD4+ T cells, cells of the monocytic lineage are infected by
HIV-1 and accumulating evidence suggests that purified CD34
positive populations of myeloid progenitor cells are susceptible
to HIV-1 infection as well (Louache et al., 1994). A greater
understanding of the molecular mechanisms of viral latency and
its reactivation is essential for eradicating HIV-1. Previous
studies demonstrated that cell–cell contact was essential for
Fig. 1. HIV-1 replication in J22-HL-60 cells induced by co-cultivation. J22-HL-
60 cells (2×105 cells/ml) were co-cultured with the equivalent number of the
indicated cell lines. Culture supernatants were collected at 24 and 48 h after
starting co-culture, and the HIV-1 p24 antigen in the supernatants was quantified
with Lumipulse. Results shown are means±SD from three independent
experiments done in duplicate.
326 X. Qi et al. / Virology 361 (2007) 325–334induction of HIV-1 replication in latently infected cell lines
(Devadas et al., 2004; Poli et al., 1994; Duh et al., 1989).
However, the mechanism of HIV-1 replication induced by cell–
cell contact in latently infected myeloid progenitor cells has
remained unknown. In the present study, the J22-HL-60 cell line,
established from HL-60 promyelocytic/myeloblastic cell line
after infection with monocyte-tropic HIV-1 JR-FL strain, was
used as a standard model.
Induction of HIV-1 replication by various extracellular
stimuli is often mediated by NF-κB, which is known to bind to
the κB sites within the HIV-1 long terminal repeat (LTR)
enhancer region (Fauci, 1996). NF-κB is a dimeric transcrip-
tion factor composed of p50, p52, RelA, RelB or c-Rel. In most
unstimulated cells, NF-κB is retained in the cytoplasm through
binding to IκB proteins, which mask the nuclear localization
signal of NF-κB. Cellular stimulation triggers phosphorylation
of specific serine residues of IκB proteins followed by its
ubiquitination and rapid proteasome-mediated degradation.
Released NF-κB then translocates to the nucleus and enhances
transcription of target genes by binding to specific consensus
sequences in their promoter region. Protease inhibitors (PIs)
such as ritonavir have been successfully used in the clinical
treatment of human immunodeficiency virus 1 (HIV-1) in-
fection, resulting in a marked decrease in HIV-1 viral load and
subsequent increase in CD4+ T-cell counts in patients (Collier
et al., 1996a, 1996b). Other investigators showed that ritonavir
suppressed proliferation of Kaposi's sarcoma and prostate
cancer cells via inhibition of NF-κB activity; ritonavir
treatment of the human dermal microvessel endothelial cells
(HMEC) blocked TNF-α-induced NF-κB activation; PIs
inhibited Toll-like receptor 2 (TLR2)- and TLR4-induced
NF-κB activation (Pati et al., 2002; Equils et al., 2004).
Ritonavir was also shown to inhibit the 20S proteasome
function (Andre et al., 1998). In this study, we demonstrate a
marked increase in virus release from J22-HL-60 cells co-
cultured with T cells, which is mediated by NF-κB and
completely ablated by ritonavir.
Results
Co-culture induces HIV-1 replication in J22-HL-60 cells
To investigate effects of cell–cell interaction on the induction
of HIV-1 replication in chronically HIV-1-infected J22-HL-60
cells, we co-cultured J22-HL-60 cells with various B and T-cell
lines such as L428, KM-H2, MOLT-4, Jurkat, MT-2 and MT-4
at a ratio of 1:1, and the viral p24 antigen released in culture
supernatants was quantified at 24 and 48 h after co-cultivation.
Although the JR-FL strain is originally infectious, HIV-1
released from J22-HL-60 cells has proved not to be infectious
(Qi et al., unpublished observation). Thus, p24 determined in
this study is derived solely from J22-HL-60 cells. As shown in
Fig. 1, co-culture strongly enhanced HIV-1 p24 release from
J22-HL-60 cells. Notably, co-culture with T-cell lines induced
p24 release from J22-HL-60 cells more efficiently than that with
B-cell lines. Since MOLT-4 cells are broadly used and also free
of known viruses, we chose this cell line for further studies.Live cell contact is required for the co-culture-induced HIV-1
replication
We compared the kinetics of virus production induced by co-
culture or TNF-α, one of the well-studied cytokines inducing
HIV-1 replication in J22-HL-60 cells. As shown in Fig. 2,
significant increase in p24 release from J22-HL-60 cells was first
noticed at 36 h after co-cultivation, which continued throughout
the experiment and finally exceeded the levels achieved by
TNF-α stimulation. In contrast, TNF-α-induced p24 production
was evident as early as 24 h after stimulation and reached a peak
around 60 h (Fig. 2).
To determine whether cell–cell contact is essential for the
induced HIV-1 expression in J22-HL-60 cells, J22-HL-60 and
MOLT-4 cells were grown in separate trans-well compartments
which allow exchange of soluble factors between the two cell
lines, but not a physical contact between J22-HL-60 and
MOLT-4 cells. As shown in Fig. 3A, p24 production was much
reduced when cells were cultured separately in trans-wells or
when J22-HL-60 cells were treated only with the supernatant of
MOLT-4 cells. These results indicate that cell–cell contact is
required for the maximal induction of HIV-1 replication in J22-
HL-60 cells after co-culture with MOLT-4 cells and that
contribution of soluble factors in supernatants is quite limited.
We next examined whether live MOLT-4 cells are necessary
for the induction of HIV-1 replication in J22-HL-60 cells after
co-culture with MOLT-4 cells. For this purpose, we used live,
heat-inactivated, or 3% paraformaldehyde-fixed MOLT-4 cells
for co-culture with J22-HL-60 cells (Fig. 3B). Neither heat-
inactivated nor paraformaldehyde-fixed MOLT-4 cells were
able to induce HIV-1 replication in J22-HL-60 cells, indicating
that this induction requires the presence of live MOLT-4 cells.
The results also suggest that the induction of HIV-1 replication
is not simply a result of allo-reactive immunological response.
Fig. 3. Live cell contact is required for the co-culture-induced HIV-1 replication.
(A) J22-HL-60 cells were either co-cultured with MOLT-4 cells, or seeded
separately in trans-well inserts, or treated with the supernatants of MOLT-4
cells. The amount of p24 antigen in the supernatants was measured with
Lumipulse at 24 and 48 h. (B) J22-HL-60 cells were co-cultured with either live,
heated or paraformaldehyde-fixed MOLT-4 cell for 24 and 48 h. The release of
p24 in the culture supernatants was quantified with Lumipulse. Results shown
are means±SD from three independent experiments done in duplicate.
Fig. 2. Kinetics of HIV-1 replication in J22-HL-60 cells. J22-HL-60 cells (2×10
5
cells/ml) were co-cultured with MOLT-4 cells (2×105 cells/ml) or treated with
TNF-α (1 ng/ml) for the indicated time periods. The p24 antigen released in
the culture supernatant was quantified with Lumipulse. Results shown are
means±SD from three independent experiments done in duplicate.
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Because some cytokines are known to induce HIV-1
replication, we investigated by RT-PCR how co-culture of J22-
HL-60 and MOLT-4 cells influences mRNA expression of
cytokines. Total RNAwas isolated 24 and 48 h after co-culture
and subjected to quantitative RT-PCR or semi-quantitative RT-
PCR analysis. The results of quantitative RT-PCR clearly
demonstrated that expression of mRNAs for IL-1β, TNF-α or
M-CSF was significantly up-regulated in the mixture of the two
types of cells at 24 and 48 h, when compared to MOLT-4 or J22-
HL-60 cells cultured independently (Fig. 4A). Semi-quantita-
tive PCR studies revealed that levels of mRNAs for other
cytokines including IL-2, IL-4, IL-8, IL-10, IFN-γ, and GM-
CSF remained unchanged after co-culture (data not shown).
Based on these results, we next tested recombinant cytokines
TNF-α, IL-1β and M-CSF for induction of HIV-1 replication in
J22-HL-60 cells. Among these, only TNF-α was able to induce
release of p24 in J22-HL-60 cells. To determine if TNF-α plays a
role in the co-culture-induced HIV-1 replication, J22-HL-60 and
MOLT-4 cells were treated with either anti-TNF-α antibody or
control mouse IgG for 3 h before and during co-culture. As
expected, anti-TNF-α antibody markedly suppressed TNF-α-
mediated induction of p24 release from J22-HL-60 cells.
However, the co-culture-induced p24 release was virtually
unaffected in the presence of anti-TNF-α antibody (Fig. 4B).
NF-κB mediates co-culture-induced p24 release
To investigate if NF-κB is involved in the co-culture-
induced p24 release, we first analyzed the phosphorylation
status of IκBα by Western blotting because phosphorylation ofIκBα usually precedes NF-κB activation induced by extra-
cellular stimuli such as TNF-α and LPS. Phosphorylation of
IκBα at the Serine 32 residue was induced in a relatively slow
kinetics with a peak at 60 to 120 min after starting co-culture of
J22-HL-60 and MOLT-4 cells (Fig. 5A, right panel), whereas
TNF-α stimulation led to a rapid phosphorylation of IκBα as
early as 5 min after stimulation. This phosphorylation decreased
at 60 min and then increased again (Fig. 5A, left panel).
Consistently, TNF-α stimulation resulted in a nearly complete
disappearance of IκBα within 30 min, while co-culture induced
a moderate decrease in IκBα 1 to 2 h later (Fig. 5A).
To further characterize the status of NF-κB activation, we
examined NF-κB DNA binding activity, using a 32P-labeled
Fig. 4. Induced expression of mRNA for cytokines in co-cultured cells. (A) cDNAs prepared from J22-HL-60 cells alone, MOLT-4 cells alone or co-cultured J22-HL-60
andMOLT-4 cells at 0, 24 or 48 h were subjected to quantitative PCR and the amount of target transcripts was normalized by 18S ribosomal RNA. The copy number of
each cytokine in J22-HL-60 cells at 0 h was taken as 100 and relative copy numbers at the indicated time points are shown. (B) J22-HL-60 and MOLT-4 cells were
treated with 1500 ng/ml of anti-TNF-α antibody at 37 °C for 2 h before and during co-culture. Released p24 in the culture supernatants was quantified with Lumipulse.
Data shown are means±SD from three independent experiments done in duplicate. Isotype-matched nonspecific antibodies were used in control experiments.
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motif. The results showed that the NF-κB DNA binding activity
reached a peak around 2 h after starting co-culture (Fig. 5B). To
know if NF-κB plays a key role in co-culture-mediated HIV-1replication, J22-HL-60 cells were infected with retrovirus
capable of expressing a super-repressor form of IκBα (SR-
IκBα) that can specifically suppress NF-κB-dependent tran-
scription (Brockman et al., 1995). The viability of J22-HL-60
Fig. 5. NF-κB mediates co-culture-induced p24 release. (A) Whole cell lysates (30 μg/lane) prepared from J22-HL-60 cells stimulated with TNF-α or co-cultured with
MOLT-4 cells for the indicated time periods were separated on a 10% polyacrylamide gel and subjected toWestern blotting with anti-phospho-IκBα, anti-IκBα or anti-
GAPDH antibodies. (B) Nuclear extracts prepared from J22-HL-60 cells, J22-HL-60 cells stimulated with 1 ng/ml of TNF-α for 30 min, MOLT-4 cells or co-cultured
J22-HL-60 and MOLT-4 cells were subjected to electrophoretic mobility shift assay with a
32P-labeled κB DNA probe. Oct-1 binding was studied in parallel to verify
equivalent loading. (C) J22-HL-60 cells stably expressing a super-repressor-IκBα (SR-IκBα) or empty vector were stimulated with TNF-α (1 ng/ml) for 30 min or co-
cultured with MOLT-4 cells for 2 h. Nuclear extracts were subjected to EMSA as described in panel B. (D) HIV-1 replication was monitored in J22-HL-60 cells stably
expressing or not SR-IκBα and either stimulated with TNF-α or co-cultured with MOLT-4 cells. Release of p24 was analyzed at 24 and 48 h later.
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shown). Infected J22-HL-60 cells were then stimulated with
TNF-α or co-cultured with MOLT-4 cells (Fig. 5C). J22-HL-60
cells expressing SR-IκBα failed to form a significant NF-κB-
specific DNA-binding complex in either case. Importantly,
expression of SR-IκBα potently suppressed HIV-1 replication
in J22-HL-60 cells either stimulated with TNF-α or co-cultured
with MOLT-4 cells (Fig. 5D). These results indicated that co-
culture activated NF-κB in a unique kinetics, which then played
an essential role in co-culture-induced HIV-1 replication in J22-
HL-60 cells.
Ritonavir blocks co-culture-induced p24 release through
inhibition of NF-κB activation
A previous study suggested that protease inhibitor (PI)
pretreatment blocks activation of NF-κB induced by TNF-α or
Toll-like receptor ligands (Equils et al., 2004). We examined ifritonavir blocks NF-κB activation induced by cell–cell contact.
Treatment with ritonavir for 2 h before and during co-culture
efficiently suppressed activation of NF-κB in a dose-dependent
manner (Fig. 6A). HIV-1 replication induced by co-culture was
almost completely inhibited by 1 μM of ritonavir (Fig. 6B).
Based on the SR-IκB results, it is reasonable to assume that
pretreatment with ritonavir ablated HIV-1 replication in co-
cultured J22-HL-60 cells through NF-κB inhibition.
CD4+ T cells stimulates HIV-1 replication in J22-HL-60 cells
Finally, we asked if primary CD4+ T cells were able to
stimulate HIV-1 replication in J22-HL-60 cells. Co-culture with
primary CD4+ T cells indeed induced p24 release from J22-HL-
60 cells, which was greatly enhanced when primary CD4+ T
cells had been stimulated with PHA before co-culture. Again,
ritonavir treatment ablated the induced replication of HIV-1 (Fig.
7A). In parallel, we monitored the evolution of expression of
Fig. 6. Ritonavir blocks co-culture-induced p24 release through inhibition of
NF-κB activating. (A) Co-cultivation of J22-HL-60 and MOLT-4 cells treated
with the indicated concentrations of ritonavir for 2 h was evaluated for NF-κB
activation. J22-HL-60 cells stimulated with TNF-α (1 ng/mL) for 30 min were
used as a positive control. Oct-1 binding was studied in parallel to verify
equivalent loading. (B) J22-HL-60 and MOLT-4 cells treated with ritonavir were
subjected to co-culture at a ratio of 1:1. The amount of p24 antigen in
supernatants was measured at 24 and 48 h after co-culture.
Fig. 7. Activated primary CD4+ T cells efficiently stimulate HIV-1 replication in
J22-HL-60 cells. (A) J22-HL-60 cells (2×10
5) were co-cultured with resting or
PHA-activated primary CD4+ T cells (1×106), which had been isolated from
PBMC by a negative selection, with or without ritonavir. The culture
supernatants were collected at day 1, day 3 and day 5 after starting co-culture
and the levels of p24 antigen were determined. (B) Resting or PHA-activated
primary CD4+ T cells were co-cultured with J22-HL-60 cells. CD25 and CD69
expression was analyzed by FACS in resting or PHA-activated primary CD4+ T
cells after co-culture with J22-HL-60 cells for 0, 1, 3 or 5 days as described in
panel A. The different features of FSC and SSC between CD4+ T cells and
J22-HL-60 cells are shown in the upper panel. Expression of CD25 and CD69 on
CD4+ T cells was monitored as described in Materials and methods. Isotype
controls were included in all assays (date not shown). Numbers in the upper
right, left and lower right quadrant indicate percentage of single or double-
positive cells. Data are representative of two independent experiments.
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J22-HL-60 cells pretreated or not with ritonavir. Co-culture with
J22-HL-60 cells increased cell surface expression of activation
markers CD25 and CD69 in a time-dependent manner, and this
activation was not affected by ritonavir (Fig. 7B).
Discussion
We have demonstrated in this study that cell–cell contact is
essential for the co-culture-induced HIV-1 replication in J22-
HL-60 cells. A variety of membrane proteins including T-cell
receptor (TCR) and major histocompatibility complex (MHC)
molecules are involved in multiple immune responses. It has
been shown that they complete their specific function
accompanied with dynamic lateral and vertical movements on
the cell membrane during the period of cell-to-cell interaction
(Baba et al., 2001). Previous studies have shown that twodistinct signals are required for the induction of cell prolifera-
tion and cytokine production in resting T cells (Chambers and
Allison, 1999; Linsley and Ledbetter, 1993). The first signal is
mediated through an interaction between peptide-loaded MHC-
II molecules located on APC and the TCR/CD3 complex
located on CD4+ T lymphocytes and the second signal is
initiated through an interaction between either CD80 or CD86
on the APC and CD28 on CD4+ T cells. In order to investigate
whether these two signals are required for the induction of HIV-
1 replication in J22-HL-60 cells by cell–cell contact, we
analyzed the expression of MHC-II molecules on J22-HL-60
cells (for first signal), CD80 or CD86 on J22-HL-60 cells and
CD28 on MOLT-4 cells (for second signal) by FACS analysis.
Our results indicated that J22-HL-60 cells express CD80 and
CD86 but not MHC-II molecules, and MOLT-4 cells does not
express CD28 (unpublished data). Therefore, these two kinds of
signal may not be involved in the case of co-cultivation of J22-
HL-60 cells and MOLT-4 cells.
Stimulation of a member of the tumor necrosis factor
receptor (TNFR) superfamily, including TNFRI (CD120a),
TNFRII (CD120b), Fas (CD95), CD40, CD30, CD27, 4-1BB
(CD137) and OX40 (CD134), by their ligand molecule has been
shown to trigger a variety of cellular activities, such as cell
growth, differentiation, immunological responses and pro-
grammed cell death (Gruss and Dower, 1995; Chougnet et al.,
2001; Herbein, 1997). In particular, TNF superfamily proteins
have been reported to enhance HIV-1 replication in cells latently
infected with HIV-1; TNF-α has been shown to enhance HIV-1
Fig. 7 (continued ).
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cell lines including J22-HL-60 cells (Matsuyama et al., 1991;
Folks et al., 1989; Matsuyama et al., 1989; Osborn et al., 1989);
gp34–OX40 interaction through cell–cell contact also induced
HIV-1 replication in latently infected T cells (Takahashi et al.,
2001). Earlier reports described that up-regulation of cytokine
expression by cell–cell contact contributes to replication ofHIV-1 in latently infected cells (Devadas et al., 2004; Borghi et
al., 2000). In our experiments, although expression of mRNA
for cytokines M-CSF, TNF-α and IL-1β was enhanced by cell–
cell contact, M-CSF and IL-1β showed no appreciable effect on
virus production in J22-HL-60 cells. Moreover, neutralizing
antibody against TNF-α was unable to inhibit co-culture-
induced HIV-1 replication. Nevertheless, we cannot exclude
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this study, and it is formally possible that such cytokines may be
secreted from activated T cells after cell–cell contact and can
stimulate J22-HL-60 cells. Paraformaldehyde-fixed MOLT-4
cells failed to induce HIV-1 replication in J22-HL-60 cells. It is
thus possible that J22-HL-60 cells somehow stimulated MOLT-4
cells initially, which in turn gave back signals to J22-HL-60 cells
and induced HIV-1 replication. This “outside-in” signaling
model is consistent with the observed delay in phosphorylation
of IκBα, degradation of IκBα and release of p24 induced by
cell–cell contact as compared to those induced by TNF-α. The
hypothesis was further supported by the evidence that primary
CD4+ T cells (both resting and PHA simulated) exhibited
elevated levels of surface activation markers CD25 and CD69
by co-culture with J22-HL-60 cells as well as induced the HIV-1
replication of J22-HL-60 cells. Moreover, PHA-simulated
primary CD4+ T cells have more efficiency on both enhanced
HIV-1 replication and the status of activation of themselves than
resting CD4+ T cells (Fig. 7).
The replication of HIV-1 is closely associated with the
activation status of its host cells and is dependent on a number
of host factors. The HIV-1 long terminal repeat (LTR) contains
at least six defined elements that bind cellular transcription
factors (Pereira et al., 2000). Among these, the best character-
ized is NF-κB, which plays important roles in cellular and viral
gene expression. In Fig. 5A, TNF-α induced a prominent
phosphorylation of IκBα as early as 5 min after stimulation,
which subsided by 60 min and then got intensified again. This is
consistent with previous reports on the oscillation of IκBα
phosphorylation and NF-κB activation following TNF-α
stimulation (Hoffmann et al., 2002; Nelson et al., 2004). In
contrast, the kinetics of IκBα phosphorylation mediated by co-
culture seemed to be slower and more persistent. This may
partly explain why co-culture-induced p24 release from J22-HL-
60 cells was not remarkable at earlier time points, but finally
exceeded that induced by TNF-α. Together with the strong
inhibition of p24 release by forced expression of SR-IκBα,
which indicates critical involvement of NF-κB activation, the
results raise two possibilities as to the mechanism of co-culture-
induced HIV-1 replication. First, NF-κB activation in J22-HL-60
cells is necessary, but the kinetics of induction may also be
important for HIV-1 replication in J22-HL-60 cells. NF-κB
activation by TNF-α is very strong and transient, while that by
cell–cell contact may relatively be weak, but rather persistent.
Second, signals from T cells that cannot be triggered by TNF-α
stimulation may potentiate co-culture-induced sustained HIV-1
replication.
Our recent study demonstrated that an HIV-1 protease
inhibitor ritonavir inhibits constitutive NF-κB activation in
HUT-102 and primary adult T-cell leukemia cells (Dewan et al.,
2006). In this study, we have found that ritonavir not only
inhibits the functions of HIV-1 protease, but also suppresses
inducible NF-κB activation and down-regulates HIV-1 release
from chronically infected cells. This suggests that cessation of an
anti-HIV-1 therapy including ritonavir may lead to activated
CD4+ T-cell-induced virion production from latently infected
cells.Materials and methods
Cell culture
J22-HL-60 is a monocytic cell line that contains one copy
of monocyte-tropic JR-FL HIV-1 strain (Kitano et al., 1990).
L428 and KM-H2 are B lymphocytic cell lines. MOLT-4,
Jurkat, MT-2 and MT-4 are T-cell lines. All the cell lines used
in this study were maintained in RPMI 1640 medium supple-
mented with 10% fetal bovine serum (FBS) (Cansera
International Inc., Canada), 100 μg/ml of penicillin and
100 μg/ml of streptomycin. J22-HL-60 cells (2×10
5/ml) and
MOLT-4 cells (2×105/ml) were co-cultured in 1.5 ml of the
regular medium at ratio of 1:1. For trans-well experiments,
J22-HL-60 cells were plated on the plastic substrate of 24-well
plates, and MOLT-4 cells were plated in the trans-well insert
in the same condition as for co-culture. Supernatants were
collected at 24 and 48 h after starting co-culture. Alternatively,
J22-HL-60 cells were treated with the supernatant of MOLT-4
cells (2×105/ml), which had been filtrated with a 0.45 μm
filter and centrifuged at 53,000 rpm for 30 min. CD4+ T cells
were isolated from PBMC by negative selection with
magnetic beads coated with antibodies that remove non-
CD4+ T cells. CD4+ T cells (1×106/ml) were washed once
with RPMI 1640 medium and co-cultured with J22-HL-60
cells (2×105/ml). For activation of CD4+ T cells, CD4+ T
cells were pretreated with PHA (5 μg/ml) 1 day before co-
culture and washed with RPMI 1640 for 3 times to remove
PHA then subjected to co-culture. Supernatants were collected
at 24 and 48 h after starting co-culture. Plat-E packaging cells
were described previously (Morita et al., 2000) and were
maintained in DMEM supplemented with 10% fetal calf
serum, blasticidin S (10 μg/ml), puromycin (1 μg/ml), peni-
cillin G (100 U/ml) and streptomycin (100 μg/ml). Plat-E cells
were transfected with pMRX-SR-IκBα-puro (pMRX-SR-
IκBα-puro was constructed by inserting an EcoRI fragment
encoding SR-IκBα into the EcoRI site of pMRX-puro) or
pMRX-puro (Nonaka et al., 2005) using fugene 6 transfection
reagent (Roche, Indianapolis, IN, USA). Culture supernatants
of Plat-E cells were collected 72 h after transfection and used
for infection of J22-HL-60 cells in the presence of 10 μg/ml of
polybrene.
Quantification of HIV-1 replication
Culture supernatants were assayed for HIV-1 p24 antigen
using an ELISA kit Lumipulse according to the manufac-
turer's instructions. Assays were performed in triplicate.
Fixation or heat treatment of MOLT-4 cells
MOLT-4 cells were washed three times in 1× PBS (pH
7.2) and incubated either at room temperature for 30 min
with 3% paraformaldehyde in 1× PBS or at 60 °C for
10 min. Cells were then washed three times with 1× PBS and
twice with RPMI 1640 medium before placing them in co-
culture.
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Total RNA was extracted using Isogen (Nippon Gene Co.,
Toyama, Japan), treated with DNase I (GIBCO BRL) and
subjected to quantitative RT-PCR. First-strand cDNA synthesis
was conducted with 1 μg of total RNA using the SuperScript
First-Strand Synthesis System for RT-PCR with random
hexamers (Invitrogen Life Technologies, Carlsbad, CA). The
amount of target transcripts was subsequently quantified by real-
time PCR using ABI 7700 sequence detector system and SYBR
green core reagent kit (Applied Biosystems) according to the
manufacturer's protocol. The PCR cycling was done with a
denaturation step at 95 °C for 10 min and 45 cycles of dena-
turation (95 °C for 15 s), annealing and extension (60 °C for
3 min). The primer sequences were as follows: for TNF-α,
forward: 5′-ACAAGCCTGTAGCCCATGTT-3′ and reverse:
5′-AAAGTAGACCTGCCCAGACT-3′; for IL-1β, forward:
5′-GGATATGGAGCAACAAGTGG-3′ and reverse: 5′-ATG-
TACCAGTTGGGGAACTG-3′; for M-CSF, forward: 5′-
ATGACCGCGCCGGGCGCCGC-3′ and reverse 5′-CTACAC-
TGGCAGTTCCACCT-3′; for 18S ribosomal RNA, forward:
5′-GTAACCCGTTGAACCCCATT-3′ and reverse: 5′-CCATC-
CAATCGGTAGTAGCG-3′. The copy number of 18S ribosomal
RNA normalized the relative copy numbers of target transcripts.
Neutralization with anti-TNF-α antibody
J22-HL-60 cells (2×10
5/ml) and MOLT-4 cells (2×105/ml)
were treated for 2 h with 1500 μg/ml anti-TNF-α antibody
(SIGMA USA) or 1500 μg/ml goat anti-mouse IgG (American
Qualex USA) and then placed in co-culture. Supernatants were
collected at 24 and 48 h after starting co-culture. Culture
supernatants were assayed for HIV p24 antigen production with
Lumipulse. Viable cell numbers were determined by trypan-
blue dye staining.
Immunoblot analysis
J22-HL-60 cells were co-cultured with MOLT-4 cells or
stimulated with TNF-α for 0, 5, 15, 30, 60, 120 or 180 min.
Cells were lysed in a lysis buffer (20 mM Tris–HCl [pH 8.0],
150 mM NaCl, 1% Triton X-100, 10% glycerol, 0.5 mM
dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 0.1%
aprotinin and 0.1% leupeptin), centrifuged at 12,000×g for
20 min at 4 °C and mixed with an equal volume of a two-fold
concentration sample buffer containing 125 mM Tris–HCl [pH
8.0], 4% sodium dodecyl sulfate (SDS), 20% glycerol, 0.004%
bromophenol blue and 2% 2-mercaptoethanol. These samples
were boiled for 5 min and then subjected to SDS-polyacryla-
mide gel electrophoresis (PAGE) on 10% separation gels; they
were then electro-blotted onto PVDF membranes (PALL Co.,
Tokyo, Japan). The membranes were treated overnight with
blocking buffer (3% skim-milk in 1× PBS) at 4 °C, washed
twice with PBS and incubated with various antibodies diluted
with 1% FCS and 0.5% Tween 20 in PBS at room temperature
for 1 h. The membranes were washed three times with 0.5%
Tween 20 in PBS and incubated with horseradish peroxidase-labeled second antibodies (Amersham International plc.,
Buckinghamshire, United Kingdom) for 1 h. After a thorough
washing, the bound antibodies were visualized with the ECL
detection reagent (Amersham) on Hyperfilm-ECL (Amersham).
Preparation of nuclear extracts
Cells were suspended in hypotonic buffer (10 mM HEPES
[pH 7.8], 10 mM KCl, 2 mM MgCl2, 1 mM DTT and 0.1 mM
EDTA) supplemented with protease and phosphatase inhi-
bitors, 0.1 mM phenylmethylsulfonyl fluoride, 1 μg/ml
leupeptin, 1 μg/ml aprotinin, 100 μM Na3VO4 and 20 mM
β-glycerophosphate. After 10 min incubation at 4 °C, Nonidet
P-40 was added to 1%. Soluble and insoluble fractions were
separated by centrifugation. The supernatant was recovered as
cytoplasmic extract and the nuclear pellet was washed with
hypotonic buffer and resuspended in extraction buffer (50 mM
HEPES [pH 7.8], 50 mM KCl, 350 mM NaCl, 0.1 mM
EDTA, 1 mM DTT, 0.1 mM PMSF, 1 μg/ml leupeptin, 1 μg/
ml aprotinin and 2.5% glycerol). After 30 min incubation at
4 °C, with occasional agitation, DNA pellets were eliminated
by centrifugation. The supernatant was recovered as a nuclear
extract.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts (5 μg) were incubated in 20 μl of binding
buffer (10 mM HEPES [pH 7.8], 100 mM NaCl, 1 mM EDTA,
2.5% glycerol containing 1 μg of poly[d(I–C)] and 0.5 ng 32P-
labeled κB probe derived from the H-2Kb promoter (Kieran et
al., 1990) or 32P-labeled Oct-1 probe (Mori et al., 2000)) and
incubated for 30 min at room temperature. Samples were run on
a 5% polyacrylamide gel containing 2.5% glycerol in 0.5× TBE
and retarded bands were revealed by autoradiography.
FACS analysis
Activation status of CD4+ T cells was examined with FITC-
conjugated anti-CD25 or PE-conjugated anti-CD69 antibodies
(DakoCytomation, Carpinteria, CA, USA). The population of
CD4+ T cells were gated out by forward and side scatter signals
(FSC/SSC) and 20,000 events were processed for each sample
at a rate of 300–500 events/s. Dot-plot statistics were calculated
by the instrument software (Cell Quest).
Acknowledgments
This work was supported by grants from the Ministry of
Education, Science, and Culture; the Ministry of Health, Labor,
and Welfare; and Human Health Science of Japan.
References
Andre, P., Groettrup, M., Klenerman, P., de Giuli, R., Booth Jr., B.L.,
Cerundolo, V., Bonneville, M., Jotereau, F., Zinkernagel, R.M., Lotteau, V.,
1998. An inhibitor of HIV-1 protease modulates proteasome activity, antigen
presentation, and T cell responses. Proc. Natl. Acad. Sci. U.S.A. 95 (22),
13120–13124.
334 X. Qi et al. / Virology 361 (2007) 325–334Baba, E., Takahashi, Y., Lichtenfeld, J., Tanaka, R., Yoshida, A., Sugamura, K.,
Yamamoto, N., Tanaka, Y., 2001. Functional CD4 T cells after intercellular
molecular transfer of 0X40 ligand. J. Immunol. 167 (2), 875–883.
Borghi, M.O., Panzeri, P., Shattock, R., Sozzani, S., Dobrina, A., Meroni, P.L.,
2000. Interaction between chronically HIV-infected promonocytic cells and
human umbilical vein endothelial cells: role of proinflammatory cytokines
and chemokines in viral expression modulation. Clin. Exp. Immunol. 120
(1), 93–100.
Brockman, J.A., Scherer, D.C., McKinsey, T.A., Hall, S.M., Qi, X., Lee, W.Y.,
Ballard, D.W., 1995. Coupling of a signal response domain in I kappa B
alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 15
(5), 2809–2818.
Bukrinsky, M.I., Stanwick, T.L., Dempsey, M.P., Stevenson, M., 1991.
Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.
Science 254 (5030), 423–427.
Chambers, C.A., Allison, J.P., 1999. Costimulatory regulation of T cell
function. Curr. Opin. Cell Biol. 11 (2), 203–210.
Chougnet, C., Freitag, C., Schito, M., Thomas, E.K., Sher, A., Shearer, G.M.,
2001. In vivo CD40–CD154 (CD40 ligand) interaction induces integrated
HIV expression by APC in an HIV-1-transgenic mouse model. J. Immunol.
166 (5), 3210–3217.
Collier, A.C., Coombs, R.W., Schoenfeld, D.A., Bassett, R.L., Timpone, J.,
Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V.J., Friedman,
H.M., Merigan, T.C., Reichman, R.C., Hooper, C., Corey, L., 1996a.
Treatment of human immunodeficiency virus infection with saquinavir,
zidovudine, and zalcitabine. N. Engl. J. Med. 334 (16), 1011–1017.
Collier, A.C., Coombs, R.W., Schoenfeld, D.A., Bassett, R., Baruch, A., Corey,
L., 1996b. Combination therapy with zidovudine, didanosine and
saquinavir. Antivir. Res. 29 (1), 99.
Devadas, K., Hardegen, N.J., Wahl, L.M., Hewlett, I.K., Clouse, K.A., Yamada,
K.M., Dhawan, S., 2004. Mechanisms for macrophage-mediated HIV-1
induction. J. Immunol. 173 (11), 6735–6744.
Dewan, M.Z., Uchihara, J.N., Terashima, K., Honda, M., Sata, T., Ito, M., Fujii,
N., Uozumi, K., Tsukasaki, K., Tomonaga, M., Kubuki, Y., Okayama, A.,
Toi, M., Mori, N., Yamamoto, N., 2006. Efficient intervention of growth and
infiltration of primary adult T-cell leukemia cells by an HIV protease
inhibitor, ritonavir. Blood 107 (2), 716–724.
Duh, E.J., Maury, W.J., Folks, T.M., Fauci, A.S., Rabson, A.B., 1989. Tumor
necrosis factor alpha activates human immunodeficiency virus type 1
through induction of nuclear factor binding to the NF-kappa B sites in
the long terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 86 (15),
5974–5978.
Equils, O., Shapiro, A., Madak, Z., Liu, C., Lu, D., 2004. Human immuno-
deficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)-
and TLR4-induced NF-kappaB activation. Antimicrob. Agents Chemother.
48 (10), 3905–3911.
Fauci, A.S., 1996. Host factors and the pathogenesis of HIV-induced disease.
Nature 384 (6609), 529–534.
Finzi, D., Hermankova, M., Pierson, T., Carruth, L.M., Buck, C., Chaisson, R.E.,
Quinn, T.C., Chadwick, K., Margolick, J., Brookmeyer, R., Gallant, J.,
Markowitz, M., Ho, D.D., Richman, D.D., Siliciano, R.F., 1997. Identifica-
tion of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.
Science 278 (5341), 1295–1300.
Folks, T.M., Clouse, K.A., Justement, J., Rabson, A., Duh, E., Kehrl, J.H.,
Fauci, A.S., 1989. Tumor necrosis factor alpha induces expression of human
immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl.
Acad. Sci. U.S.A. 86 (7), 2365–2368.
Gruss, H.J., Dower, S.K., 1995. Tumor necrosis factor ligand superfamily:
involvement in the pathology of malignant lymphomas. Blood 85 (12),
3378–3404.
Herbein, G., 1997. Cytokines, viruses and macrophages: an interactive network.
An immune dysregulation involving the members of the tumor necrosis
factor (TNF) receptor superfamily could be critical in AIDS pathogenesis.
Pathol. Biol. 45 (2), 115–125.
Hoffmann, A., Levchenko, A., Scott, M.L., Baltimore, D., 2002. The IkappaB–NF-kappaB signaling module: temporal control and selective gene
activation. Science 298 (5596), 1241–1245.
Kieran, M., Blank, V., Logeat, F., Vandekerckhove, J., Lottspeich, F., Le Bail,
O., Urban, M.B., Kourilsky, P., Baeuerle, P.A., Israel, A., 1990. The DNA
binding subunit of NF-kappa B is identical to factor KBF1 and homologous
to the rel oncogene product. Cell 62 (5), 1007–1018.
Kitano, K., Baldwin, G.C., Raines, M.A., Golde, D.W., 1990. Differentiating
agents facilitate infection of myeloid leukemia cell lines by monocytotropic
HIV-1 strains. Blood 76 (10), 1980–1988.
Linsley, P.S., Ledbetter, J.A., 1993. The role of the CD28 receptor during T cell
responses to antigen. Annu. Rev. Immunol. 11, 191–212.
Louache, F., Debili, N., Marandin, A., Coulombel, L., Vainchenker, W., 1994.
Expression of CD4 by human hematopoietic progenitors. Blood 84 (10),
3344–3355.
Matsuyama, T., Yoshiyama, H., Hamamoto, Y., Yamamoto, N., Soma, G.,
Mizuno, D., Kobayashi, N., 1989. Enhancement of HIV replication and
giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses
5 (2), 139–146.
Matsuyama, T., Kobayashi, N., Yamamoto, N., 1991. Cytokines and HIV infec-
tion: is AIDS a tumor necrosis factor disease? AIDS 5 (12), 1405–1417.
Mori, N., Fujii, M., Iwai, K., Ikeda, S., Yamasaki, Y., Hata, T., Yamada, Y.,
Tanaka, Y., Tomonaga, M., Yamamoto, N., 2000. Constitutive activation of
transcription factor AP-1 in primary adult T-cell leukemia cells. Blood 95
(12), 3915–3921.
Morita, S., Kojima, T., Kitamura, T., 2000. Plat-E: an efficient and stable system
for transient packaging of retroviruses. Gene Ther. 7 (12), 1063–1066.
Nelson, D.E., Ihekwaba, A.E., Elliott, M., Johnson, J.R., Gibney, C.A., Foreman,
B.E., Nelson, G., See, V., Horton, C.A., Spiller, D.G., Edwards, S.W.,
McDowell, H.P., Unitt, J.F., Sullivan, E., Grimley, R., Benson, N.,
Broomhead, D., Kell, D.B., White, M.R., 2004. Oscillations in NF-kappaB
signaling control the dynamics of gene expression. Science 306 (5696),
704–708.
Nonaka, M., Horie, R., Itoh, K., Watanabe, T., Yamamoto, N., Yamaoka, S.,
2005. Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg
cells and CD30-transformed rat fibroblasts. Oncogene 24 (24), 3976–3986.
Osborn, L., Kunkel, S., Nabel, G.J., 1989. Tumor necrosis factor alpha and
interleukin 1 stimulate the human immunodeficiency virus enhancer by
activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U.S.A. 86 (7),
2336–2340.
Pati, S., Pelser, C.B., Dufraine, J., Bryant, J.L., Reitz Jr., M.S., Weichold, F.F.,
2002. Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition
of Kaposi sarcoma. Blood 99 (10), 3771–3779.
Pereira, L.A., Bentley, K., Peeters, A., Churchill, M.J., Deacon, N.J., 2000. A
compilation of cellular transcription factor interactions with the HIV-1 LTR
promoter. Nucleic Acids Res. 28 (3), 663–668.
Pierson, T., McArthur, J., Siliciano, R.F., 2000. Reservoirs for HIV-1:
mechanisms for viral persistence in the presence of antiviral immune
responses and antiretroviral therapy. Annu. Rev. Immunol. 18, 665–708.
Poli, G., Kinter, A.L., Fauci, A.S., 1994. Interleukin 1 induces expression of the
human immunodeficiency virus alone and in synergy with interleukin 6 in
chronically infectedU1 cells: inhibition of inductive effects by the interleukin
1 receptor antagonist. Proc. Natl. Acad. Sci. U.S.A. 91 (1), 108–112.
Pomerantz, R.J., Horn, D.L., 2003. Twenty years of therapy for HIV-1 infection.
Nat. Med. 9 (7), 867–873.
Siliciano, J.D., Kajdas, J., Finzi, D., Quinn, T.C., Chadwick, K., Margolick, J.B.,
Kovacs, C., Gange, S.J., Siliciano, R.F., 2003. Long-term follow-up studies
confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.
Nat. Med. 9 (6), 727–728.
Takahashi, Y., Tanaka, Y., Yamashita, A., Koyanagi, Y., Nakamura, M.,
Yamamoto, N., 2001. OX40 stimulation by gp34/OX40 ligand enhances
productive human immunodeficiency virus type 1 infection. J. Virol. 75
(15), 6748–6757.
Wong, J.K., Hezareh, M., Gunthard, H.F., Havlir, D.V., Ignacio, C.C., Spina,
C.A., Richman, D.D., 1997. Recovery of replication-competent HIV despite
prolonged suppression of plasma viremia. Science 278 (5341), 1291–1295.
